Jinxiong I. Huang

Xiamen, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Tolerability and pharmacokinetics of leritrelvir in Chinese participants with severe renal impairment and healthy matched control subjects.

Tolerability and pharmacokinetics of leritrelvir in Chinese participants with severe renal impairment and healthy matched control subjects.

Journal: British journal of clinical pharmacology

Published: September 17, 2025

RhTSH in aiding dynamic assessment in patients with differentiated thyroid Cancer.

RhTSH in aiding dynamic assessment in patients with differentiated thyroid Cancer.

Journal: European journal of nuclear medicine and molecular imaging

Published: April 09, 2025

Development and Evaluation of 68Ga-Labeled TMTP1-Based Cyclic Peptide Probes for Targeting Hepatocellular Carcinoma.

Development and Evaluation of 68Ga-Labeled TMTP1-Based Cyclic Peptide Probes for Targeting Hepatocellular Carcinoma.

Journal: Molecular pharmaceutics

Published: February 24, 2025

A preclinical and first-in-human study of superstable homogeneous radiolipiodol for revolutionizing interventional diagnosis and treatment of hepatocellular carcinoma.

A preclinical and first-in-human study of superstable homogeneous radiolipiodol for revolutionizing interventional diagnosis and treatment of hepatocellular carcinoma.

Journal: Acta pharmaceutica Sinica. B

Published: December 01, 2024

FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics.

FAP-targeted delivery of radioiodinated probes: A progressive albumin-driven strategy for tumor theranostics.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: October 04, 2024

Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types.

Rational Design and Comparison of Novel 99mTc-Labeled FAPI Dimers for Visualization of Multiple Tumor Types.

Journal: Journal of medicinal chemistry

Published: May 08, 2024

68Ga-Labeled TMTP1 Modified with d-Amino Acid for Positron Emission Tomography Diagnosis of Highly Metastatic Hepatocellular Carcinoma.

68Ga-Labeled TMTP1 Modified with d-Amino Acid for Positron Emission Tomography Diagnosis of Highly Metastatic Hepatocellular Carcinoma.

Journal: Journal of medicinal chemistry

Published: January 25, 2024

In Vivo Comparative Study of Radioiodinated Folate Receptor Targeting Albumin Probes for Atherosclerosis Plaque Imaging.

In Vivo Comparative Study of Radioiodinated Folate Receptor Targeting Albumin Probes for Atherosclerosis Plaque Imaging.

Journal: Bioconjugate chemistry

Published: December 06, 2023

Longitudinal MicroSPECT Imaging of Systemic Sclerosis Model Mice with [99mTc]Tc-HYNFA via Folate Receptor Targeting.

Longitudinal MicroSPECT Imaging of Systemic Sclerosis Model Mice with [99mTc]Tc-HYNFA via Folate Receptor Targeting.

Journal: Molecular pharmaceutics

Published: October 28, 2022

Novel Radiolabeled TMTP1 for Long-Acting Hepatocellular Carcinoma Therapeutics.

Novel Radiolabeled TMTP1 for Long-Acting Hepatocellular Carcinoma Therapeutics.

Journal: Molecular pharmaceutics

Published: August 16, 2022

PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor Effect.

PD-L1-Targeted Radionuclide Therapy Combined with αPD-L1 Antibody Immunotherapy Synergistically Improves the Antitumor Effect.

Journal: Molecular pharmaceutics

Published: June 02, 2022

A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti-PD-L1 mAb Combination to Enhance the Antitumor Effect.

A Paradigm of Cancer Immunotherapy Based on 2-[18F]FDG and Anti-PD-L1 mAb Combination to Enhance the Antitumor Effect.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 17, 2022

Showing 1-12 of 19

Last Updated: 09/26/2026